scholarly article | Q13442814 |
P356 | DOI | 10.1042/AN20120016 |
P8608 | Fatcat ID | release_q3fmu2acqrdtxl5fw5a62qfjdm |
P932 | PMC publication ID | 3342594 |
P698 | PubMed publication ID | 22471445 |
P2093 | author name string | David N Irani | |
Emily K Rainey-Barger | |||
Nilufer Esen | |||
Pennelope K Blakely | |||
P2860 | cites work | Functional role of type I and type II interferons in antiviral defense | Q24276429 |
IRF7: activation, regulation, modification and function | Q24299740 | ||
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs | Q24303416 | ||
B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5 | Q24309316 | ||
Toll-like receptor signalling | Q24570126 | ||
A novel Toll-like receptor that recognizes vesicular stomatitis virus | Q24622356 | ||
UNC93B1 mediates host resistance to infection with Toxoplasma gondii | Q27313711 | ||
Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism | Q27469650 | ||
Control of Sindbis virus infection by antibody in interferon-deficient mice | Q27469654 | ||
Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatment | Q27480314 | ||
The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis | Q27480965 | ||
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses | Q27860455 | ||
Toll-like receptors | Q27860671 | ||
Innate immune recognition | Q27860721 | ||
The alphaviruses: gene expression, replication, and evolution | Q27860954 | ||
Pathogen recognition and innate immunity | Q27861084 | ||
A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
Herpes simplex virus encephalitis in human UNC-93B deficiency | Q28263759 | ||
UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes | Q28270473 | ||
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9 | Q28292044 | ||
A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen | Q28300225 | ||
The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling | Q28590478 | ||
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice | Q81332054 | ||
CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses | Q33771205 | ||
Activation of divergent neuronal cell death pathways in different target cell populations during neuroadapted sindbis virus infection of mice | Q33787166 | ||
Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication. | Q33825385 | ||
Lymphoid chemokines in the CNS. | Q34020894 | ||
Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. | Q34052870 | ||
BCL-2 and BAX protect adult mice from lethal Sindbis virus infection but do not protect spinal cord motor neurons or prevent paralysis | Q34348333 | ||
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) | Q34375520 | ||
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group | Q34730962 | ||
Role of specific innate immune responses in herpes simplex virus infection of the central nervous system | Q35826453 | ||
Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. | Q35857229 | ||
The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease | Q36537921 | ||
Recognition of Staphylococcus aureus-derived peptidoglycan (PGN) but not intact bacteria is mediated by CD14 in microglia | Q36647941 | ||
Pathogenesis of encephalitis induced in newborn mice by virulent and avirulent strains of Sindbis virus | Q36805448 | ||
The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis | Q36965275 | ||
Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses | Q36990637 | ||
Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. | Q37151168 | ||
Lymphoid chemokines in chronic neuroinflammation | Q37186200 | ||
Regulatory molecules required for nucleotide-sensing Toll-like receptors | Q37361434 | ||
The role of differential expression of human interferon--a genes in antiviral immunity. | Q37571025 | ||
Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands | Q39791660 | ||
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. | Q39808939 | ||
Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. | Q41344793 | ||
Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis | Q42102380 | ||
Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis | Q42411798 | ||
Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis | Q42840679 | ||
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. | Q43227358 | ||
Glutamate receptor antagonists protect from virus-induced neural degeneration | Q43910026 | ||
Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. | Q45030474 | ||
PRODUCTION OF INTERFERON BY NEWBORN AND ADULT MICE INFECTED WITH SINDBIS VIRUS. | Q45714824 | ||
Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection | Q45749972 | ||
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response | Q48177195 | ||
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group | Q48550791 | ||
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitis | Q48708626 | ||
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis | Q57912405 | ||
Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid | Q59543689 | ||
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group | Q70650973 | ||
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group | Q77573170 | ||
P433 | issue | 4 | |
P921 | main subject | encephalitis | Q199615 |
microglia | Q1622829 | ||
P304 | page(s) | 207-221 | |
P577 | publication date | 2012-05-03 | |
P1433 | published in | ASN Neuro | Q20312578 |
P1476 | title | Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice | |
P478 | volume | 4 |
Q41809363 | Activation of intrinsic immune responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile virus infection |
Q37162262 | An ENU-induced splicing mutation reveals a role for Unc93b1 in early immune cell activation following influenza A H1N1 infection |
Q36501695 | An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo |
Q63246307 | Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease |
Q33731184 | Buggy Creek virus (Togaviridae: Alphavirus) upregulates expression of pattern recognition receptors and interferons in House Sparrows (Passer domesticus) |
Q29198018 | Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis |
Q34992649 | Differentiation of neurons restricts Arbovirus replication and increases expression of the alpha isoform of IRF-7. |
Q36476035 | Endogenous adaptation to low oxygen modulates T-cell regulatory pathways in EAE. |
Q59353759 | Genetic control of alphavirus pathogenesis |
Q47364751 | Innate immune control of alphavirus infection |
Q59350636 | Interferon regulatory factors 3 and 7 have distinct roles in the pathogenesis of alphavirus encephalomyelitis |
Q36494832 | MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1 |
Q37300377 | Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis |
Q33772300 | Regulated Production of CXCL13 within the Central Nervous System |
Q36551188 | Targeting CXCL13 During Neuroinflammation |
Q41487141 | Unc93b1 -Dependent Endosomal Toll-Like Receptor Signaling Regulates Inflammation and Mortality during Coxsackievirus B3 Infection. |
Search more.